Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Elite Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Elite Pharmaceuticals's pe ratio was 5.0× on Oct 19, 2026, against 44.3× a year earlier. Over the last 5 years it ranged from 4.0× to 53.2×, with a median of 9.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 5.0× | −44.0 |
| 2025 | Dec 31, 2025 | 49.0× | +4.7 |
| 2024 | Oct 31, 2024 | 44.3× | +30.3 |
| 2023 | Dec 29, 2023 | 14.0× | +9.3 |
| 2022 | Dec 30, 2022 | 4.7× | −0.7 |
| 2021 | Dec 31, 2021 | 5.3× | −13.8 |
| 2020 | Dec 31, 2020 | 19.2× | −94.4 |
| 2017 | Oct 31, 2017 | 113.5× | +29.9 |
| 2016 | Dec 30, 2016 | 83.6× | +15.8 |
| 2015 | Dec 31, 2015 | 67.8× | +1.6 |
| 2014 | Jan 31, 2014 | 66.1× | +39.7 |
| 2013 | Dec 31, 2013 | 26.5× | +20.4 |
| 2012 | Oct 31, 2012 | 6.0× | – |
See a number that looks wrong?